Candel Therapeutics: director Nicoletta Loggia received 380 shares

What happened Nicoletta Loggia, a director, received an award of 380 derivative shares, acquired at $8.68 per share for a total value of $3,297, according to the Form 4 filed on Oct 2, 2026.

Key details

• Transaction date and price: Sep 30, 2026 — award (code A) of 380 shares at $8.68 per share.
• Classification: derivative securities (acquired).
• Shares owned after the transaction: the filing does not report the total shares owned after the transaction.
• Footnote F1: "This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant."
• Filing date: Oct 2, 2026. The filing does not indicate it was filed late.

Why it may matter

• This was an award/grant of derivative shares, not a market purchase or sale.
• A filing does not show why the insider traded or why the company acted.